Ultromics
Ultromics provides AI software that analyzes echocardiograms to help clinicians identify patients with heart failure with preserved ejection fraction and cardiac amyloidosis.
Ultromics has raised €87M across 3 funding rounds from 18 investors, most recently a Series C round in Jul 2025. Based in Oxford, UK; active in Healthtech. Data as of 28 Oct 2026.
Oxford, UKwww.ultromics.com ↗
Total raised
€87M
€87,426,991
Funding rounds
3
Investors
18
distinct backers
Active since
2018-02
latest 2025-07
Funding by year
EUR raised per yearUltromics — funding by year — interactive chart.
Data table
| Ultromics — funding by year | |
|---|---|
| 2018 | €11M |
| 2021 | €28M |
| 2025 | €48M |
Signals
High confidenceRaise-next likelihood80
base rate 50% for Series C
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood23
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 8y since founding (typical exit age)
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-07-31 | Series C | €48M | Allegis Capital,Blue Venture Fund,GV,L&G Capital,Lightrock,Oxford Science Enterprises+3 more | View deal → |
| 2021-08-16 | Series B | €28M | Blue Venture Fund,GV,Optum Ventures,Oxford Sciences Innovation | View deal → |
| 2018-02-01 | Series A | €11M | Andre Crawford-Brunt,Dieter Spälti.,Fushia,GT Healthcare Capital & Partners,Neptune,Oxford Sciences Innovation+2 more | View deal → |
Investors
18Related news
- UK-based Ultromics raises €28M to help clinicians diagnose heart disease using AI; here’s howsiliconcanals.com · 2021-08
- tech.eu
- tech.eu
Similar companies
same sector or countryGlobal coverage: FundingData